NIPENT

Formula & Concentration

NIPENT- pentostatin injection, powder, lyophilized, for solution

Manufacturer

Pfizer Inc.

Indications

NIPENT is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.

Product Options

Package Size

NDC #

Presentation

10 mg

00409-0801-01

Vial

Shelf Life and Storage

Store NIPENT vials under refrigerated storage conditions 2° to 8° C (36° to 46°F).